Laparoscopic adjustable gastric banding for the treatment of morbid obesity - 01/09/11
, Michael H Scott a : Ch.M., Annemarie S Brown a : M.B., Ch.B., John Rogers, M.D. cAbstract |
Background: This prospective study evaluated the effectiveness and safety of laparoscopic adjustable gastric banding (LAGB) for morbid obesity.
Methods: Ninety-five consecutive patients (89 female; median age 38 years, range 19 to 69) underwent LAGB for morbid obesity. Median weight and body mass index were 123.2 (88.9 to 228.6) kg and 45 (32.7-76.4) kg/m2 respectively. Significant coexistent disease was present in 52 (55%) patients.
Results: Median excess weight loss was 53% (range 96.9% to 12.1%) and 62% (range 107.5% to 32.3%) at 1 and 2 years respectively (P <0.001). Median operative time was 90 (range 35 to 285) minutes and inpatient stay 2 (range 1 to 10) days. Early complications were seen in 17 (18%) patients most commonly nausea/vomiting or dysphagia. Late complications were seen in 25 (26.3%) patients, most frequently vomiting or reflux due to band slippage or pouch dilatation. There was 1 (1%) operative death.
Conclusions: LAGB is an effective operation for morbid obesity that results in equivalent weight loss to open surgical procedures.
Le texte complet de cet article est disponible en PDF.Keywords : Morbid obesity, Gastric banding, Laparoscopy, Complications, Weight loss
Plan
Vol 184 - N° 2
P. 97-102 - août 2002 Retour au numéro
Article précédent
- Implementation of sentinel lymph node biopsy for breast cancer by surgeons in the Department of Defense
- Kurt G Davis, John P Schriver, Brad Waddell
- Obesity and its surgical management
- Edward H Livingston
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?